PsyBio Therapeutics Corp. PSYBF
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.005 Day range 0.005
0.00001 52-week range 0.005
- YTD
- 0.00%
- 1 year
- -90.00%
- Market cap
- 1.27K
- YTD return
- 0.00%
- 1-year return
- -90.00%
- Volume
- 8.00K
- Open
- 0.005
- Previous close
- 0.00001
- Day's range
- 0.005 – 0.005
- 52-week range
- 0.00001 – 0.005
2Y -0.0050 (-99.80%)
News
PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale 
Cannabis Movers & Shakers: Burns & Levinson, Water Ways, Chill Brands, Rubicon Organics 
PsyBio Therapeutics successfully completes first pre-IND meeting with the FDA 
PsyBio Therapeutics presents 16 scientific abstracts highlighting its research and development efforts at two scientific conferences 
PsyBio Therapeutics shares updates on intellectual property and clinical development milestones 
PsyBio Therapeutics is developing psychoactive compounds which could be a mental health game changer 
PsyBio Therapeutics announces expansion of its intellectual property portfolio by filing six additional patent applications 
PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th 
PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility 
PsyBio Therapeutics submits its first pre-IND application meeting request to FDA
Your note
Sign in to keep a note on PSYBF — it syncs with the Stock Master app.